×
Supernus Pharmaceuticals Total Assets 2011-2024 | SUPN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Supernus Pharmaceuticals total assets from 2011 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
View More
Supernus Pharmaceuticals Total Assets 2011-2024 | SUPN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Supernus Pharmaceuticals total assets from 2011 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$24.9B
Dr Reddy's Laboratories (RDY)
$12.6B
BridgeBio Pharma (BBIO)
$6.8B
Bausch Health Cos (BHC)
$2.8B
Amphastar Pharmaceuticals (AMPH)
$1.7B
Personalis (PSNL)
$396M
Taysha Gene Therapies (TSHA)
$314M
Assembly Biosciences (ASMB)
$95M
Sol-Gel Technologies (SLGL)
$25M
Evoke Pharma (EVOK)
$6M
Teligent (TLGT)
$0M